WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005123721) AMORPHOUS AND POLYMORPHIC FORMS OF CANDESARTAN CILEXETIL
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/123721    International Application No.:    PCT/IB2005/001739
Publication Date: 29.12.2005 International Filing Date: 20.06.2005
IPC:
C07D 403/10 (2006.01), A61K 31/415 (2006.01), A61P 9/02 (2006.01)
Applicants: RANBAXY LABORATORIES LIMITED [IN/IN]; Plot No. 90, Sector-32, Gurgaon, Haryana 122001, Delhi (IN) (For All Designated States Except US).
KUMAR, Yatendra [IN/IN]; (IN) (For US Only).
DE, Shantanu [IN/IN]; (IN) (For US Only).
SATHYANARAYANA, Swargam [IN/IN]; (IN) (For US Only)
Inventors: KUMAR, Yatendra; (IN).
DE, Shantanu; (IN).
SATHYANARAYANA, Swargam; (IN)
Common
Representative:
RANBAXY LABORATORIES LIMITED; c/o DESHMUKH, Jay, R., 600 College Road East, Suite 2100, Princeton, NJ 08540 (US)
Priority Data:
1154/Del/2004 18.06.2004 IN
1312/Del/2004 16.07.2004 IN
Title (EN) AMORPHOUS AND POLYMORPHIC FORMS OF CANDESARTAN CILEXETIL
(FR) FORMES AMORPHES ET POLYMORPHES DE CANDESARTAN CILEXETIL
Abstract: front page image
(EN)The present invention provides a storage-stable, substantially pure amorphous form of candesartan cilexetil. The present invention further provides novel polymorphic forms of candesartan cilexetil, process for preparation and pharmaceutical compositions thereof for antagonizing angiotensin II. The novel polymorphic forms have been designated as Form A and Form B of candesartan cilexetil.
(FR)La présente invention concerne une forme amorphe sensiblement pure de candesartan cilexetil. Elle concerne également de nouvelles formes polymorphes de candesartan cilexetil, un procédé de préparation et des compositions pharmaceutiques pour antagoniser l'angiotensine II. Les nouvelles formes polymorphes ont état désignées 'forme A' et 'forme B' de candesartan cilexetil.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)